XML 35 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Investments:    
Fixed Maturities at Fair Value (Amortized Cost: 2023 - $7,565.8; 2022 - $7,811.8 Allowance for Credit Losses: 2023 - $8.2; 2022 - $9.6) $ 6,881.9 $ 6,894.8
Equity Securities at Fair Value (Cost: 2023 - $209.3; 2022 - $247.6) 225.8 243.2 [1]
Other Investments 241.9 269.9 [1]
Total Investments 8,904.2 8,789.5 [1]
Cash 64.1 212.4 [1]
Receivables from Policyholders (Allowance for Credit Losses: 2023 - $13.9; 2022 - $13.1) 959.5 1,286.6 [1]
Other Receivables 200.5 262.6 [1]
Deferred Policy Acquisition Costs 591.6 635.6 [1]
Goodwill 1,250.7 1,300.3 [1]
Current Income Tax Assets 64.5 167.6 [1]
Deferred Income Tax Assets 210.4 129.0 [1]
Other Assets 492.6 530.0 [1]
Total Assets 12,742.7 13,313.6 [1]
Insurance Reserves:    
Life and Health 3,422.4 3,276.2 [2]
Property and Casualty 2,680.5 2,756.9 [2]
Total Insurance Reserves 6,102.9 6,033.1 [2]
Unearned Premiums 1,300.8 1,704.4 [2]
Policyholder Obligations 655.7 701.3 [2]
Deferred Income Tax Liabilities 50.6 0.0 [2]
Accrued Expenses and Other Liabilities 737.7 817.3 [2]
Long-term Debt, Current and Non-current, at Amortized Cost (Fair Value: 2023 - $1,213.4; 2022 - $1,195.1) 1,389.2 1,386.9 [2]
Total Liabilities 10,237.7 10,643.0 [2]
Kemper Corporation Shareholders’ Equity:    
Common Stock, $0.10 Par Value, 100,000,000 Shares Authorized; 64,111,555 Shares Issued and Outstanding at December 31, 2023 and 63,912,762 Shares Issued and Outstanding at December 31, 2022 6.4 6.4 [2]
Paid-in Capital 1,845.3 1,812.7 [2]
Retained Earnings 1,014.3 1,366.4 [2]
Accumulated Other Comprehensive Loss (360.8) (514.9) [2]
Total Shareholders’ Equity 2,505.2 2,670.6 [2]
Total Liabilities and Shareholders’ Equity 12,742.7 13,313.6 [2]
Equity Securities at Modified Cost 513.5 586.5 [1]
Convertible Securities at Fair Value 281.2 283.4 [1]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2,505.0 2,670.6 [3]
Variable Interest Entity, Primary Beneficiary    
Investments:    
Fixed Maturities at Fair Value (Amortized Cost: 2023 - $7,565.8; 2022 - $7,811.8 Allowance for Credit Losses: 2023 - $8.2; 2022 - $9.6) 1.7 0.0 [1]
Other Short-Term Investments 2.0 0.0 [1]
Receivables from Policyholders (Allowance for Credit Losses: 2023 - $13.9; 2022 - $13.1) 0.7 0.0 [1]
Deferred Policy Acquisition Costs 0.1 0.0
Deferred Income Tax Assets 0.1 0.0
Insurance Reserves:    
Unearned Premiums 0.5 0.0 [2]
Accrued Expenses and Other Liabilities 0.3 0.0 [2]
Consolidated Entity, Excluding Consolidated VIE    
Investments:    
Fixed Maturities at Fair Value (Amortized Cost: 2023 - $7,565.8; 2022 - $7,811.8 Allowance for Credit Losses: 2023 - $8.2; 2022 - $9.6) 6,881.9 6,894.8 [1]
Other Short-Term Investments 520.9 278.4 [1]
Alternative Energy Partnership Investments    
Investments:    
Equity Method Investments 17.3 16.3 [1]
Equity Method Limited Liability Investments    
Investments:    
Equity Method Investments $ 221.7 $ 217.0 [1]
[1] As of January 1, 2023, the Company adopted ASU 2018-12 using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been recast to reflect application of the new guidance. See Note 2 to the Consolidated Financial Statements for additional information.
[2] As of January 1, 2023, the Company adopted ASU 2018-12 using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been recast to reflect application of the new guidance. See Note 2 to the Consolidated Financial Statements for additional information.
[3] As of January 1, 2023, the Company adopted ASU 2018-12 using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been recast to reflect application of the new guidance. See Note 2 to the Consolidated Financial Statements for additional information.